Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin-12 Receptor Beta 1 Subunit (IL-12Rβ1) is a type I transmembrane protein and a member of the hemopoietin receptor superfamily. It forms receptor complexes with IL-12Rβ2 and IL-23R to bind IL-12 and IL-23, respectively, mediating Th1 and Th17 immune responses. Mutations in IL12RB1 are associated with immunodeficiency and increased susceptibility to mycobacterial and Salmonella infections.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 12 Receptor Beta 1 Subunit (IL-12Rβ1).